Literature DB >> 23804551

Residual shunting after percutaneous PFO closure: how to manage and how to close.

Gianfranco Butera1, Javier Fernandez Sarabia, Antonio Saracino, Massimo Chessa, Luciane Piazza, Mario Carminati.   

Abstract

INTRODUCTION: Initial transcatheter Percutaneous patent foramen ovale (PFO) closure attempt may be incomplete and result in persistent residual shunting. The optimal treatment strategy for these patients remains unknown. PATIENTS AND METHODS: Twenty-seven patients were diagnosed to have a moderate-large residual shunt at least 12 months after initial PFO closure associated or not to a recurrent ischemic event and underwent a second procedure. Residual shunt characteristics were classified in two types: Type I: tunnel-like or between the disk defect (11 patients); Type II: accessory defect next to a device rim or accessory defect (16 patients).
RESULTS: Fourteen subjects had a recurrent transient ischemic attack/stroke (52%). Median time between the first and the second PFO closure procedure was 17 months (range 12-60 months). Deployment of a second device was successful in 92% (25/27) patients. A Type I defect was closed by using a coil or Amplatzer Vascular Plugs. In two patients a surgical option was chosen as a first option. A Type II defect was closed by using a double disc device. At a median follow-up of 36 months (range 12-60 months), two subjects showed significant residual shunting between the two disks of the device (Type I) at 12 months follow-up and were sent to surgery.
CONCLUSIONS: Significant residual shunts can be successfully closed by using a second device. Care is required to select an optimal device depending on anatomy and original device. In some subjects, lack of endothelial covering account for the persistence of a significant residual shunting.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac catheterization; cryptogenic stroke; patent foramen ovale; transcatheter closure

Mesh:

Year:  2013        PMID: 23804551     DOI: 10.1002/ccd.25097

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  A Prospective, Single-Center, Phase I Clinical Trial to Evaluate the Value of Transesophageal Echocardiography in the Closure of Patent Foramen Ovale With a Novel Biodegradable Occluder.

Authors:  Yajuan Du; Hang Xie; Hui Shao; Gesheng Cheng; Xingye Wang; Xumei He; Beidi Lan; Lu He; Yushun Zhang
Journal:  Front Cardiovasc Med       Date:  2022-05-03

2.  Midterm follow-up of transthoracic device closure of an atrial septal defect using the very large domestic occluder (44-48 mm), a single Chinese cardiac center experience.

Authors:  Qiang Chen; Hua Cao; Gui-Can Zhang; Liang-Wan Chen; Fan Xu; Jia-Xin Zhang
Journal:  J Cardiothorac Surg       Date:  2017-09-02       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.